Etubics Corporation - Product Pipeline Review

Global Markets Direct’s, ‘Etubics Corporation - Product Pipeline Review - 2016’, provides an overview of the Etubics Corporation’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Etubics Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Etubics Corporation

The report provides overview of Etubics Corporation including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Etubics Corporation’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Etubics Corporation’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Etubics Corporation’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Etubics Corporation

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Etubics Corporation’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Etubics Corporation Snapshot 5

Etubics Corporation Overview 5

Key Information ...

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Etubics Corporation Snapshot 5

Etubics Corporation Overview 5

Key Information 5

Key Facts 5

Etubics Corporation - Research and Development Overview 6

Key Therapeutic Areas 6

Etubics Corporation - Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products - Monotherapy 10

Etubics Corporation - Pipeline Products Glance 11

Etubics Corporation - Clinical Stage Pipeline Products 11

Phase I Products/Combination Treatment Modalities 11

Etubics Corporation - Early Stage Pipeline Products 12

Preclinical Products/Combination Treatment Modalities 12

Discovery Products/Combination Treatment Modalities 13

Etubics Corporation - Drug Profiles 14

ETBX-011 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

Ebola vaccine 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

ETBX-021 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

Gene Therapy for Auditory Disorders 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

Gene Therapy to Activate Acid Alpha-Glucosidase for Pompe Disease 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

HIV vaccine 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

influenza [strain H1N1] (mutivalent) vaccine 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Vaccine for HPV Associated Head and Neck Squamous Cell Carcinoma 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Vaccine for Oncology 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

chikungunya vaccine 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

lassa fever vaccine 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

Etubics Corporation - Pipeline Analysis 26

Etubics Corporation - Pipeline Products by Target 26

Etubics Corporation - Pipeline Products by Route of Administration 27

Etubics Corporation - Pipeline Products by Molecule Type 28

Etubics Corporation - Pipeline Products by Mechanism of Action 29

Etubics Corporation - Recent Pipeline Updates 30

Etubics Corporation - Dormant Projects 32

Etubics Corporation - Locations and Subsidiaries 33

Head Office 33

Appendix 34

Methodology 34

Coverage 34

Secondary Research 34

Primary Research 34

Expert Panel Validation 34

Contact Us 34

Disclaimer 35

List of Tables

List of Tables

Etubics Corporation, Key Information 5

Etubics Corporation, Key Facts 5

Etubics Corporation - Pipeline by Indication, 2016 8

Etubics Corporation - Pipeline ...

List of Tables

Etubics Corporation, Key Information 5

Etubics Corporation, Key Facts 5

Etubics Corporation - Pipeline by Indication, 2016 8

Etubics Corporation - Pipeline by Stage of Development, 2016 9

Etubics Corporation - Monotherapy Products in Pipeline, 2016 10

Etubics Corporation - Phase I, 2016 11

Etubics Corporation - Preclinical, 2016 12

Etubics Corporation - Discovery, 2016 13

Etubics Corporation - Pipeline by Target, 2016 26

Etubics Corporation - Pipeline by Route of Administration, 2016 27

Etubics Corporation - Pipeline by Molecule Type, 2016 28

Etubics Corporation - Pipeline Products by Mechanism of Action, 2016 29

Etubics Corporation - Recent Pipeline Updates, 2016 30

Etubics Corporation - Dormant Developmental Projects,2016 32

List of Figures

List of Figures

Etubics Corporation - Pipeline by Top 10 Indication, 2016 7

Etubics Corporation - Pipeline by Stage of Development, 2016 9

Etubics Corporation ...

List of Figures

Etubics Corporation - Pipeline by Top 10 Indication, 2016 7

Etubics Corporation - Pipeline by Stage of Development, 2016 9

Etubics Corporation - Monotherapy Products in Pipeline, 2016 10

Etubics Corporation - Pipeline by Target, 2016 26

Etubics Corporation - Pipeline by Route of Administration, 2016 27

Etubics Corporation - Pipeline by Molecule Type, 2016 28

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports